C07K 16/085
Orthoherpesviridae
Official title: Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
C07K16/085 (Orthoherpesviridae) appears on 283 US grants and 372 published applications in this corpus.
Search patents in C07K- Granted patents
- 283
- Published applications
- 372
- Assignees
- 256
- Inventors
- 779
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 6 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 8 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 14 | 0 |
| 1999 | 5 | 0 |
| 2000 | 8 | 0 |
| 2001 | 10 | 1 |
| 2002 | 5 | 4 |
| 2003 | 4 | 7 |
| 2004 | 1 | 7 |
| 2005 | 4 | 8 |
| 2006 | 6 | 8 |
| 2007 | 2 | 7 |
| 2008 | 3 | 8 |
| 2009 | 2 | 5 |
| 2010 | 5 | 10 |
| 2011 | 6 | 8 |
| 2012 | 12 | 19 |
| 2013 | 9 | 19 |
| 2014 | 12 | 19 |
| 2015 | 8 | 18 |
| 2016 | 10 | 23 |
| 2017 | 12 | 11 |
| 2018 | 14 | 24 |
| 2019 | 10 | 13 |
| 2020 | 10 | 23 |
| 2021 | 13 | 31 |
| 2022 | 13 | 16 |
| 2023 | 4 | 27 |
| 2024 | 18 | 24 |
| 2025 | 12 | 18 |
| 2026 | 9 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof30 Jun 2026US 12,668,645 B2ModeX Therapeutics, Inc.
- Antibody to Epstein Barr virus and uses thereof2 Jun 2026US 12,643,939 B2The Council of the Queensland Institute of Medical Research
- De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals26 May 2026US 12,637,495 B2Molecular Templates, Inc.
- Chimeric antigen receptors against human cytomegalovirus12 May 2026US 12,624,083 B2City of Hope
- Systems to produce B cells genetically modified to express selected antibodies31 Mar 2026US 12,589,145 B2Fred Hutchinson Cancer Center
- Methods and compositions comprising purified recombinant polypeptides1 Oct 2026US 2026/0297179 A1Genentech, Inc.
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Novel Anti-HSV Antibody10 Sep 2026US 2026/0265348 A1Heidelberg ImmunoTherapeutics GmbH
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Tetz-proteins and prion-like proteins and associated methods6 Aug 2026US 2026/0227416 A1
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001
- Polynucleotides encoding improved humanized immunoglobulins1,258US 5,693,761 AProtein Design Labs, Inc. · 1997